ShareValue scores for ALSPW.PA: Valuation 74, Quality 56, Growth 56, Health 47.
ALSPW.PAEuronext Paris
Spineway
€0.12
(+0.33%)
ALSPW.PAEuronext Paris
Spineway
€0.12(+0.33%)
Loading chart...
Sentiment
Verdicts
Value:Undervalued
Quality:Moderate
Growth:Moderate
Health:Moderate
Verdicts
Fundamental Rating
Value Trap Risk
Expected Return
15% to 28%
Rating
Trap Risk
Return
15% to 28%
Valuation
74
Undervalued
Price vs Value
Quality
56
Moderate
Business Strength
Growth
56
Moderate
Revenue & Earnings
Health
47
Moderate
Financial Stability
Momentum
51
Neutral
Price Trend
Company Details
About
Spineway SA designs, develops, and markets a range of surgical implants for spine in France. The company offers posterior fixation, including posterior osteosynthesis systems and minimal invasive posterior osteosynthesis systems; interbody fusion products, such as lumbar cage twin peaks tlif curved and oblique; motion preservation products; and biomaterials. It also exports its products. The company was incorporated in 2005 and is headquartered in Ecully, France.
Market Cap$4M
P/E RatioN/A
Dividend YieldNone
Sector Rank#421
Score Analysis
AI Investment Thesis
Data as of:Jun 29, 2026
|Last calculated:Jun 29, 2026